Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.599493
Abstract: MYC/BCL2/BCL6 triple-hit lymphoma (THL) is an uncommon subset of high-grade B-cell lymphoma with aggressive clinical behavior and poor prognosis. TP53 mutation is an independently poor progonistic indicator in patients with THL, hence novel therapeutic strategies…
read more here.
Keywords:
triple hit;
car19 cells;
therapy;
car19 ... See more keywords